» Articles » PMID: 17600515

Temporal Characterization of Mitochondrial Bioenergetics After Spinal Cord Injury

Overview
Journal J Neurotrauma
Publisher Mary Ann Liebert
Date 2007 Jun 30
PMID 17600515
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial dysfunction following spinal cord injury (SCI) may be critical for the development of secondary pathophysiology and neuronal cell death. Previous studies have demonstrated a loss of mitochondrial bioenergetics at 24 h following SCI. To begin to understand the evolution and study the contribution of mitochondrial dysfunction in pathophysiology of SCI, we investigated mitochondrial bioenergetics in the mid-thoracic region at 6, 12, and 24 h following contusion SCI. It is widely accepted that increased free radical generation plays a critical role in neuronal damage after SCI. Hence, to ascertain the role of free radicals in SCI-induced mitochondrial dysfunction, markers for oxidative damage, including nitrotyrosine (3-NT), lipid peroxidation byproduct (4-hydroxynonenal [HNE]), and protein oxidation (protein carbonyls) were quantified in the same samples of isolated mitochondria during the 24-h time course. The results demonstrate that a significant decline in mitochondrial function begins to occur 12 h post-injury and persists for a least 24 h following SCI. Furthermore, there was a progressive increase in mitochondrial oxidative damage that preceded the loss of mitochondrial bioenergetics, suggesting that free radical damage may be a major mitochondrial secondary injury process. Based on the present results, the temporal profile of mitochondrial dysfunction indicates that interventions targeting mitochondrial oxidative damage and dysfunction may serve as a beneficial pharmacological treatment for acute SCI.

Citing Articles

A reactive oxygen species-responsive hydrogel loaded with Apelin-13 promotes the repair of spinal cord injury by regulating macrophage M1/M2 polarization and neuroinflammation.

Li Z, Zhao Q, Zhou J, Li Y, Zheng Y, Chen L J Nanobiotechnology. 2025; 23(1):12.

PMID: 39794784 PMC: 11724542. DOI: 10.1186/s12951-024-02978-4.


Ketone Esters Partially and Selectively Rescue Mitochondrial Bioenergetics After Acute Cervical Spinal Cord Injury in Rats: A Time-Course.

Seira O, Park H, Liu J, Poovathukaran M, Clarke K, Boushel R Cells. 2024; 13(21.

PMID: 39513853 PMC: 11545339. DOI: 10.3390/cells13211746.


Metabolic reprogramming: a new option for the treatment of spinal cord injury.

Chen J, Chen J, Yu C, Xia K, Yang B, Wang R Neural Regen Res. 2024; 20(4):1042-1057.

PMID: 38989936 PMC: 11438339. DOI: 10.4103/NRR.NRR-D-23-01604.


Molars to Medicine: A Focused Review on the Pre-Clinical Investigation and Treatment of Secondary Degeneration following Spinal Cord Injury Using Dental Stem Cells.

Jenkner S, Clark J, Gronthos S, OHare Doig R Cells. 2024; 13(10.

PMID: 38786039 PMC: 11119219. DOI: 10.3390/cells13100817.


Mitochondria-Targeted Antioxidant Therapeutics for Traumatic Brain Injury.

Modi H, Musyaju S, Ratcliffe M, Shear D, Scultetus A, Pandya J Antioxidants (Basel). 2024; 13(3).

PMID: 38539837 PMC: 10967339. DOI: 10.3390/antiox13030303.